Hormone replacement therapy and risk of epithelial ovarian cancer

@article{Purdie1999HormoneRT,
  title={Hormone replacement therapy and risk of epithelial ovarian cancer},
  author={David M. Purdie and Christopher J. Bain and V. Siskind and P. J. Russell and N F Hacker and Bruce G. Ward and Michael A. Quinn and Ad{\`e}le C Green},
  journal={British Journal of Cancer},
  year={1999},
  volume={81},
  pages={559 - 563}
}
SummaryIt has been suggested that oestrogen replacement therapy is associated with risk of epithelial ovarian cancer of the endometrioid type. Using data from an Australian population-based case–control study, the relation between unopposed oestrogen replacement therapy and epithelial ovarian cancer, both overall and according to histological type, was examined. A total of 793 eligible incident cases of epithelial ovarian cancer diagnosed from 1990 to 1993 among women living in Queensland, New… CONTINUE READING

4 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Post - menopausal oestrogen replacement therapy may , therefore , be a risk factor associated with endometrioid and clear cell tumours in particular .
Post - menopausal oestrogen replacement therapy may , therefore , be a risk factor associated with endometrioid and clear cell tumours in particular .
No clear associations were observed between use of hormone replacement therapy overall and risk of ovarian cancer .
No clear associations were observed between use of hormone replacement therapy overall and risk of ovarian cancer .
All Topics